معرفی
Michael H. Bloch, M.D., M.S., is an Associate Professor at the Yale Child Study Center within the Yale School of Medicine. He is the Director and Co-Founder of the Pediatric Depression Clinic and Co-Director of the Tic and OCD Program. He also serves as Associate Program Director of the Albert J. Solnit Integrated Training Program and Associate Training Director of the Child Study Center’s psychiatry residency program.
- Education: MD, Yale University School of Medicine (2004); MS, Chronic Disease Epidemiology, Yale University (2009); BA, Biology, University of Pennsylvania (2000)
- Board Certifications: Psychiatry and Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology
Dr. Bloch's research is centered on evidence-based treatments for childhood and adult neuropsychiatric disorders. His primary areas of interest include Tourette syndrome, OCD, trichotillomania, ADHD, depression, and anxiety. He employs clinical trials and meta-analyses to evaluate pharmacological and behavioral interventions, with a particular focus on treatment-resistant conditions and novel therapeutics such as ketamine.
His recent publications demonstrate a strong trend in meta-analytic methodologies applied to pediatric psychopharmacology, including dose-response relationships of SSRIs in OCD, stimulant dosing in ADHD, and ketamine’s efficacy in adolescent depression and suicidality. His work frequently appears in high-impact journals such as The Lancet Child & Adolescent Health, Molecular Psychiatry, and the American Journal of Psychiatry.
Scientific recognition includes:
- Samuel Ritvo Teaching Award (2024)
- Norbert and Charlotte Rieger Award for Scientific Achievement (2013)
- Seymour L. Lustman Award for Psychiatry Research (2009)
- Associate Member, American College of Neuropsychopharmacology
- NIH Loan Repayment Program Award
Dr. Bloch mentors trainees through the T32 Postdoctoral Research Fellowship in Childhood Neuropsychiatric Disorders and leads NIH-funded clinical trials, including studies on ketamine for adolescent suicidality and neurofeedback for Tourette syndrome. He also serves on the editorial boards of several leading journals, including the Journal of the American Academy of Child and Adolescent Psychiatry and Depression and Anxiety.
He is actively involved in the Bloch Lab, part of the Clinical Neuroscience Research Unit at Yale, focusing on translational research in neurodevelopmental and mood disorders. His team collaborates extensively with researchers such as James Leckman, Angeli Landeros-Weisenberger, and John Krystal.
حوزههای پژوهشی